US Stock MarketDetailed Quotes

Tenax Therapeutics (TENX)

Watchlist
  • 11.910
  • -0.260-2.14%
Close May 13 15:59 ET
  • 12.090
  • +0.180+1.51%
Post 18:33 ET
315.91MMarket Cap-8.45P/E (TTM)

Tenax Therapeutics (TENX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-33.62%-9.31M
-141.71%-35.8M
-280.35%-13.42M
-196.57%-9.16M
-106.63%-6.26M
-34.86%-6.97M
-150.86%-14.81M
-200.17%-3.53M
-48.33%-3.09M
-228.40%-3.03M
Net income from continuing operations
-51.00%-15.72M
-198.82%-52.6M
-147.97%-15.54M
-298.99%-15.8M
-203.41%-10.85M
-173.97%-10.41M
-128.27%-17.6M
-94.27%-6.27M
-100.86%-3.96M
-223.14%-3.58M
Operating gains losses
----
----
----
----
----
----
----
----
-60.59%14.59K
-53.69%22.06K
Depreciation and amortization
----
----
----
----
----
----
--0
--0
--0
--0
Other non cash items
----
----
----
----
----
----
-4.17%23K
-135.10%-1K
-15.10%7K
6.35%9K
Change In working capital
609.13%3.57M
-243.88%-2.36M
-250.48%-2.67M
20.40%1.03M
-104.87%-25K
53.08%-701K
3.79%1.64M
-11.71%1.77M
648.89%853K
306.27%513K
-Change in receivables
----
----
----
----
----
6,900.00%1.22M
118.95%58K
44.41%-360.67K
-148.86%-240.93K
230.78%677.6K
-Change in prepaid assets
82.92%2.24M
-8,422.41%-4.83M
-792.24%-3.22M
-1,169.17%-3.05M
--216K
--1.22M
--58K
---361K
---240K
----
-Change in payables and accrued expense
169.09%1.33M
55.39%2.46M
-73.92%556K
272.64%4.07M
-46.95%-241K
-30.42%-1.93M
-16.09%1.59M
-19.69%2.13M
1,965.54%1.09M
-108.72%-164K
Cash from discontinued investing activities
Operating cash flow
-33.62%-9.31M
-141.71%-35.8M
-280.35%-13.42M
-196.57%-9.16M
-106.63%-6.26M
-34.86%-6.97M
-150.86%-14.81M
-200.17%-3.53M
-48.33%-3.09M
-228.40%-3.03M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
Net PPE purchase and sale
----
----
----
----
----
----
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
29.44%30.5M
-61.44%38.51M
17,229.85%11.61M
-96.67%3.06M
307.46%278K
197.40%23.56M
636.02%99.87M
138.37%67K
53,820.45%92.01M
-34.12%-134K
Net issuance payments of debt
----
--0
--0
--0
--0
--0
19.71%-501K
--0
-62.89%-279K
20.31%-134K
Net common stock issuance
----
----
----
----
----
----
----
----
32,632.55%91.95M
--0
Proceeds from stock option exercised by employees
29.44%30.5M
-61.63%38.51M
17,229.85%11.61M
-96.68%3.06M
--278K
194.13%23.56M
607.19%100.37M
-99.51%67K
--92.29M
--0
Net other financing activities
----
----
----
----
----
----
----
----
----
--0
Cash from discontinued financing activities
Financing cash flow
29.44%30.5M
-61.44%38.51M
17,229.85%11.61M
-96.67%3.06M
307.46%278K
197.40%23.56M
636.02%99.87M
138.37%67K
53,820.45%92.01M
-34.12%-134K
Net cash flow
Beginning cash position
2.86%97.57M
868.66%94.85M
1.08%99.37M
1,023.85%105.46M
788.09%111.45M
868.66%94.85M
361.02%9.79M
782.41%98.31M
-29.94%9.38M
-12.94%12.55M
Current changes in cash
27.68%21.19M
-96.81%2.71M
47.86%-1.8M
-106.85%-6.09M
-89.10%-5.99M
501.96%16.6M
1,009.27%85.06M
-156.40%-3.46M
4,048.03%88.93M
-209.91%-3.17M
End cash Position
6.56%118.76M
2.86%97.57M
2.86%97.57M
1.08%99.37M
1,023.85%105.46M
788.09%111.45M
868.66%94.85M
868.66%94.85M
782.41%98.31M
-29.94%9.38M
Free cash flow
-33.62%-9.31M
-141.71%-35.8M
-280.35%-13.42M
-196.57%-9.16M
-106.63%-6.26M
-34.86%-6.97M
-150.86%-14.81M
-200.17%-3.53M
-48.33%-3.09M
-228.40%-3.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -33.62%-9.31M-141.71%-35.8M-280.35%-13.42M-196.57%-9.16M-106.63%-6.26M-34.86%-6.97M-150.86%-14.81M-200.17%-3.53M-48.33%-3.09M-228.40%-3.03M
Net income from continuing operations -51.00%-15.72M-198.82%-52.6M-147.97%-15.54M-298.99%-15.8M-203.41%-10.85M-173.97%-10.41M-128.27%-17.6M-94.27%-6.27M-100.86%-3.96M-223.14%-3.58M
Operating gains losses ---------------------------------60.59%14.59K-53.69%22.06K
Depreciation and amortization --------------------------0--0--0--0
Other non cash items -------------------------4.17%23K-135.10%-1K-15.10%7K6.35%9K
Change In working capital 609.13%3.57M-243.88%-2.36M-250.48%-2.67M20.40%1.03M-104.87%-25K53.08%-701K3.79%1.64M-11.71%1.77M648.89%853K306.27%513K
-Change in receivables --------------------6,900.00%1.22M118.95%58K44.41%-360.67K-148.86%-240.93K230.78%677.6K
-Change in prepaid assets 82.92%2.24M-8,422.41%-4.83M-792.24%-3.22M-1,169.17%-3.05M--216K--1.22M--58K---361K---240K----
-Change in payables and accrued expense 169.09%1.33M55.39%2.46M-73.92%556K272.64%4.07M-46.95%-241K-30.42%-1.93M-16.09%1.59M-19.69%2.13M1,965.54%1.09M-108.72%-164K
Cash from discontinued investing activities
Operating cash flow -33.62%-9.31M-141.71%-35.8M-280.35%-13.42M-196.57%-9.16M-106.63%-6.26M-34.86%-6.97M-150.86%-14.81M-200.17%-3.53M-48.33%-3.09M-228.40%-3.03M
Investing cash flow
Cash flow from continuing investing activities 0000
Net PPE purchase and sale --------------------------0--0--0--0
Cash from discontinued investing activities
Investing cash flow --------------0--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 29.44%30.5M-61.44%38.51M17,229.85%11.61M-96.67%3.06M307.46%278K197.40%23.56M636.02%99.87M138.37%67K53,820.45%92.01M-34.12%-134K
Net issuance payments of debt ------0--0--0--0--019.71%-501K--0-62.89%-279K20.31%-134K
Net common stock issuance --------------------------------32,632.55%91.95M--0
Proceeds from stock option exercised by employees 29.44%30.5M-61.63%38.51M17,229.85%11.61M-96.68%3.06M--278K194.13%23.56M607.19%100.37M-99.51%67K--92.29M--0
Net other financing activities --------------------------------------0
Cash from discontinued financing activities
Financing cash flow 29.44%30.5M-61.44%38.51M17,229.85%11.61M-96.67%3.06M307.46%278K197.40%23.56M636.02%99.87M138.37%67K53,820.45%92.01M-34.12%-134K
Net cash flow
Beginning cash position 2.86%97.57M868.66%94.85M1.08%99.37M1,023.85%105.46M788.09%111.45M868.66%94.85M361.02%9.79M782.41%98.31M-29.94%9.38M-12.94%12.55M
Current changes in cash 27.68%21.19M-96.81%2.71M47.86%-1.8M-106.85%-6.09M-89.10%-5.99M501.96%16.6M1,009.27%85.06M-156.40%-3.46M4,048.03%88.93M-209.91%-3.17M
End cash Position 6.56%118.76M2.86%97.57M2.86%97.57M1.08%99.37M1,023.85%105.46M788.09%111.45M868.66%94.85M868.66%94.85M782.41%98.31M-29.94%9.38M
Free cash flow -33.62%-9.31M-141.71%-35.8M-280.35%-13.42M-196.57%-9.16M-106.63%-6.26M-34.86%-6.97M-150.86%-14.81M-200.17%-3.53M-48.33%-3.09M-228.40%-3.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More